The startup Healx has developed a novel treatment allocation method allowing prediction of drug response, writes Kate Sweeney in Business Weekly. “We believe the impact could be enormous, including for the healthcare system,” said Tim Guilliams, founder of Healx. The start-up is supported by the Accelerate Cambridge programme at Cambridge Judge Business School.
Read the full article [businessweekly.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments